German Pharmaceuticals & Biotech Potentially Undervalued Companies

SynBiotic

Market Cap: €21.9m

Engages in the research and development, production, and marketing of cannabinoid and terpene-based solutions to for pain, sleep deprivation, and anxiety.

Alvotech

Market Cap: €3.4b

Through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide.

CanSino Biologics

Market Cap: €11.9b

Develops, manufactures, and commercializes vaccines in the People’s Republic of China.

Atara Biotherapeutics

Market Cap: €46.5m

Engages in the development of transformative therapies for patients with cancer and autoimmune disease in the United States and the United Kingdom.

Gilead Sciences

Market Cap: €134.9b

A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

Orion Oyj

Market Cap: €8.1b

Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.

Orexo

Market Cap: €507.9m

A specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, the United Kingdom, and internationally.

Aelis Farma

Market Cap: €16.4m

A clinical-stage biopharmaceutical company, focuses on discovering and developing drug candidates for the treatment of central nervous system disorders in France.

Rezolute

Market Cap: €239.1m

A late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States.

SynBiotic

Market Cap: €21.9m

Engages in the research and development, production, and marketing of cannabinoid and terpene-based solutions to for pain, sleep deprivation, and anxiety.

Astellas Pharma

Market Cap: €2.5t

Manufactures, markets, and imports and exports pharmaceuticals in Japan and internationally.

Sino Biopharmaceutical

Market Cap: €79.1b

An investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China.

Revolution Medicines

Market Cap: €7.0b

A clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers.

SKAN Group

Market Cap: €1.6b

Provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally.

Cannabist Company Holdings

Market Cap: €27.0m

The Cannabist Company Holdings Inc. cultivates, manufactures, and sells cannabis products and related services for the medical and adult-use markets in the United States and internationally.

Eledon Pharmaceuticals

Market Cap: €188.6m

Operates as a clinical stage biotechnology company.

Biotage

Market Cap: €11.3b

Provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing.

Orion Oyj

Market Cap: €8.1b

Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.

Viva Biotech Holdings

Market Cap: €3.9b

An investment holding company, engages in the provision of structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide.

Tecan Group

Market Cap: €2.1b

Provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally.